Shockwave Medical(@ShockwaveIVL):For International Audiences: COSIRA was the first randomized sham-controlled trial studying the use of #ShockwaveReducer for refractory angina. This pivotal trial demonstrated that patients who received Shockwave Reducer achieved a statistically significant improvement in angina symptoms and quality of life compared to patients in the sham control group. Explore the COSIRA results: https://t.co/2MZHQ3WLSc Verheye S. et al. Coronary sinus reducer for treatment of refractory angina: the COSIRA trial. N Engl J Med. 2015;372:519-27. Safety Info: https://t.co/as4irbY3DX CAUTION: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada.

2026.06.25 09:00

For International Audiences: COSIRA was the first randomized sham-controlled trial studying the use of #ShockwaveReducer# for refractory angina. This pivotal trial demonstrated that patients who received Shockwave Reducer achieved a statistically significant improvement in angina symptoms and quality of life compared to patients in the sham control group. Explore the COSIRA results: Verheye S. et al. Coronary sinus reducer for treatment of refractory angina: the COSIRA trial. N Engl J Med. 2015;372:519-27. Safety Info: CAUTION: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada.